Starling Oncology, Inc. Proceeds from Lines of Credit
Starling Oncology, Inc. (STLN) reported Proceeds from Lines of Credit of $0 for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2022-05-10
- Starling Oncology, Inc. proceeds from lines of credit for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. proceeds from lines of credit for the quarter ending 2021-03-31 was $2.50M.
| Period end | Proceeds from Lines of Credit 3 month |
|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 |
| 2021-03-31 | $2.50M 10-Q · filed 2022-05-10 |